UnknownPhase 4

Comparison Between Hyperbaric Bupivacaine With Fentanyl vs. Hyperbaric Bupivacaine With Dexmedetomidine in Reducing Visceral Pain During Cesarean Delivery Under Spinal Anaesthesia

168 participantsStarted 2024-04

Plain-language summary

In patients undergoing elective LSCS under subarachnoid block, group BF will receive 0.5% hyperbaric bupivacaine 10mg (2ml) with fentanyl 10 mcg (0.2ml) with total of 2.2 ml and group BD will receive 0.5% hyperbaric bupivacaine 10 mg with Dexmedetomidine 5mcg (0.2ml) total volume 2.2ml. Assessment of intraoperative visceral pain will be done by self-reporting of patients, who are previously educated, as poorly localized discomfort or dragging, pulling heaviness or unpleasant feeling or pain with or without nausea and will be categorized according to preformed scale

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Elective caesarean deliveries under SAB * ASA PS II * Age ≥18 years * Term pregnancy ≥37 weeks of gestation * Height ≥ 150 Exclusion Criteria: * Patients with medical disorder in pregnancy (neurological, psychiatric, cardiopulmonary, * hepatorenal diseases, coagulopathy) * Patient refusal to participate * Allergy or hypersensitivity to LA, fentanyl or dexmedetomidine * Patients with communication problem * Patient with bradycardia (HR- less than 60)

What they're measuring

Primary outcome

Timeframe: Intraoperative

Trial details

NCT IDNCT06367660

SponsorTribhuvan University Teaching Hospital, Institute Of Medicine.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08

Contact for this trial

Sujan Dhakal

9851325896 szndkl44@gmail.com

View on ClinicalTrials.gov More Visceral Pain trials